Article
Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions.
Biological psychiatry - 1 Sept 2016
Demers Catherine H, Drabant Conley Emily, Bogdan Ryan, Hariri Ahmad R
Abstract excerpt
BACKGROUND: Preclinical models reveal that stress-induced amygdala activity and impairment in fear extinction reflect reductions in anandamide driven by corticotropin-releasing factor receptor type 1 (CRF1) potentiation of the anandamide catabolic enzyme fatty acid amide hydrolase. METHODS: Here, we provide clinical translation for the importance of these molecular interactions using an imaging genetics strategy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
